Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine for Postoperative Delirium
NCT00257868Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Jan 2006
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Rivastigmine with Placebo (2 arms). Primary endpoint: Development of postoperative delirium at 7 days. Started Jan 2006; status: completed.
02
Drugs
rivastigmine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT00257868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257868.